Glossary
A
- Active ingredient
- Adverse effect
- Agonist
- Allergenics
- Ames test
- Antagonist
- Approved drug
- Associated condition
- ATC codes
B
- Binding Strength
- Biodegradation
- Biotech drug
- Black box warning
- Blood brain barrier
- Boiling point
C
- Caco-2 permeable
- Carcinogenicity
- Carrier
- CAS Number
- Cell transplant therapies
- Chemical Formula
- Clinical trial
- Condition
- Contraindication
- CYP450 1A2 substrate ADMET Feature Prediction
- CYP450 2C19 inhibitor ADMET Feature Prediction
- CYP450 2C9 inhibitor ADMET Feature Prediction
- CYP450 2C9 substrate ADMET Feature Prediction
- CYP450 2D6 inhibitor ADMET Feature Prediction
- CYP450 2D6 substrate ADMET Feature Prediction
- CYP450 3A4 inhibitor ADMET Feature Prediction
- CYP450 3A4 substrate ADMET Feature Prediction
- CYP450 inhibitory promiscuity
- Cytochrome P-450 Interactions
D
- Dosage form
- Dosage route
- Drug
- Drug active moiety
- Drug Binding
- Drug Card
- Drug Group
- Drug Identification Number (DIN)
- Drug Indication
- Drug interaction
- Drug label
- Drug patent
- Drug Product
E
- Enzyme
- Ester prodrug
- Evidence level
- Evidence type
- Experimental drug
- Experimental property
F
- Food interaction
- Formulation Strength
G
- Gene therapies
H
- hERG inhibition (predictor I)
- hERG inhibition (predictor II)
- Human Intestinal Absorption
- Hydrophobicity
I
- ICD10
- Illicit drug
- Inactive ingredient
- InChI
- InChI key
- Inducer
- Inhibitor
- Investigational drug
- Isoelectric point
- IUPAC Name
J
K
L
- Lipinski's rule of five
- Log S
- LogP
M
- Management
- Mechanism of Action
- MedDRA
- Melting point
- Metabolic Reaction
- Metabolite
- Molecular Weight
N
- Narrow Therapeutic Index Drug
- National Drug Code (NDC)
- Nucleic acid based therapies
- Nutraceutical drug
O
- Off label
P
- P-glycoprotein inhibitor I ADMET Feature Prediction
- P-glycoprotein inhibitor II ADMET Feature Prediction
- P-glycoprotein substrate ADMET Feature Prediction
- Pharmacological Action
- pKa
- Polypeptide
- Predicted ADMET features
- Predicted Bioavailability
- Predicted property
- Product Concept
- Protein based therapies
Q
R
- Radioactivity
- Rat acute toxicity ADMET Feature Prediction
- Reaction Type
- Renal organic cation transporter ADMET Feature Prediction
S
- Salt
- Severity
- Small Molecule Drug
- SMILES
- SNP
- Substrate
T
- Target
- Transporter
U
V
- Vaccines
- Vet approved drug
W
- Water solubility
- Withdrawn drug
X
Y
Z
- Field Descriptions
- FAQ's
- Release Notes
Documentation
- CSV Format
- JSON Format
- XML Format
Documentation
- Clinical API
- Scientific API
Drug active moiety
Synonyms:
- Active moiety
- Drug moiety
- Moieties
- Moiety
This concept refers to the characteristic part of the active ingredient; excluding the appended portions of the molecule such as esters, salts or non-covalent derivatives; that presents the physiological and pharmacological actions correspondent to the drug.1
References:
- FDA regulations [Link]
